Literature DB >> 1603292

Cigarette smoking and nicotine gum (0, 2 and 4 mg): effects upon four visual attention tasks.

A C Parrott1, D Craig.   

Abstract

Sixteen regular smokers, abstinent for 12 h prior to testing, were assessed on a battery of four visual attention tasks: rapid visual information processing (RVIP), letter cancellation, Stroop, and width of attention. Each subject was assessed under four conditions: placebo gum, 2 mg nicotine gum, 4 mg nicotine gum, and cigarette smoking (own brand), with the order of drug administration determined by latin square. Pre-post drug difference scores for letter cancellation response time demonstrated a significant monotonic dose-response function, with significantly faster performance following cigarette than placebo. RVIP response time and target detection were also affected by nicotine. One RVIP task parameter demonstrated a significant monotonic dose-response function, with highest performance under smoking. Other RVIP measures demonstrated curvilinear dose-response functions, with highest performance under nicotine gum, and broadly similar performance after placebo gum and cigarette smoking. Monotonic and inverted-U arousal/performance functions similar to these have been demonstrated in previous research with nicotine. In contrast to the significant changes in sustained attention, neither width of attention nor Stroop task performance (an index of distractability) was affected by nicotine. Resting heart rate and subjective 'need for a cigarette' showed the predicted monotonic dose-response functions following nicotine. There were no significant changes in any Profile of Mood State factor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1603292     DOI: 10.1159/000118807

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  22 in total

1.  The early time course of smoking withdrawal effects.

Authors:  Peter S Hendricks; Joseph W Ditre; David J Drobes; Thomas H Brandon
Journal:  Psychopharmacology (Berl)       Date:  2006-06-03       Impact factor: 4.530

2.  Effects of cigarette smoking and abstinence on Stroop task performance.

Authors:  Catherine P Domier; John R Monterosso; Arthur L Brody; Sara L Simon; Adrianna Mendrek; Richard Olmstead; Murray E Jarvik; Mark S Cohen; Edythe D London
Journal:  Psychopharmacology (Berl)       Date:  2007-07-19       Impact factor: 4.530

Review 3.  Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.

Authors:  P A Newhouse; A Potter; E D Levin
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

4.  Lower subcortical gray matter volume in both younger smokers and established smokers relative to non-smokers.

Authors:  Colleen A Hanlon; Max M Owens; Jane E Joseph; Xun Zhu; Mark S George; Kathleen T Brady; Karen J Hartwell
Journal:  Addict Biol       Date:  2014-08-13       Impact factor: 4.280

5.  Olfactory identification and Stroop interference converge in schizophrenia.

Authors:  S E Purdon
Journal:  J Psychiatry Neurosci       Date:  1998-05       Impact factor: 6.186

6.  Effects of transdermal nicotine and concurrent smoking on cognitive performance in tobacco-abstinent smokers.

Authors:  Bethea A Kleykamp; Janine M Jennings; Thomas Eissenberg
Journal:  Exp Clin Psychopharmacol       Date:  2011-02       Impact factor: 3.157

7.  Performance effects of nicotine during selective attention, divided attention, and simple stimulus detection: an fMRI study.

Authors:  Britta Hahn; Thomas J Ross; Frank A Wolkenberg; Diaa M Shakleya; Marilyn A Huestis; Elliot A Stein
Journal:  Cereb Cortex       Date:  2008-12-10       Impact factor: 5.357

8.  Sex differences in hormonal responses to stress and smoking relapse: a prospective examination.

Authors:  Mustafa al'Absi; Motohiro Nakajima; Sharon Allen; Andrine Lemieux; Dorothy Hatsukami
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

9.  Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder.

Authors:  Alexandra S Potter; Paul A Newhouse
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

10.  Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia.

Authors:  L Elliot Hong; Matthew Schroeder; Thomas J Ross; Brittany Buchholz; Betty Jo Salmeron; Ikwunga Wonodi; Gunvant K Thaker; Elliot A Stein
Journal:  Schizophr Bull       Date:  2009-08-27       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.